Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Lamotrigine in rapid-cycling bipolar disorder
S. H. Fatemi
, D. J. Rapport
, J. R. Calabrese
,
P. Thuras
Psychiatry & Behavioral Sciences
Research output
:
Contribution to journal
›
Article
›
peer-review
133
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Lamotrigine in rapid-cycling bipolar disorder'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Lamotrigine
100%
Rapid Cycling Bipolar Disorder
100%
Beck Depression inventory-II (BDI-II)
50%
Global Assessment Scale
40%
Rapid Cycling
30%
Bipolar Patients
30%
Monotherapy
20%
Time Effect
20%
Regression Modeling
20%
Random Regression
20%
Young Mania Rating Scale
20%
Modeling Analysis
10%
Non-responders
10%
Antidepressants
10%
Treatment Effect
10%
Depressive Symptoms
10%
Augmentation Therapy
10%
DSM-IV
10%
Minimum Effective Dose
10%
Stabilizing Effect
10%
Dosage Effect
10%
T-statistic
10%
Anticonvulsant
10%
Stabilizing Agent
10%
Score Following
10%
Social Function
10%
Change Analysis
10%
Partial Responder
10%
Antidepressant Efficacy
10%
Well Tolerated
10%
Pharmacology, Toxicology and Pharmaceutical Science
Lamictal
100%
Rapid Cycling Bipolar Disorder
100%
Antidepressant
20%
Psychotropic Agent
20%
Monotherapy
20%
Prospective Study
10%
Mood Stabilizer
10%
Anticonvulsive Agent
10%
DSM-IV
10%
Side Effect
10%
Neuroscience
Lamotrigine
100%
Rapid Cycling Bipolar Disorder
100%
Beck Depression Inventory
50%
Antidepressant
20%
Mood Stabilizer
10%
Psychoactive Drug
10%
Anticonvulsant
10%
Side Effect
10%
Medicine and Dentistry
Rapid Cycling Bipolar Disorder
100%